9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Giant low-grade primary myofibroblastic sarcoma of the posterior chest wall

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Primary myofibroblastic sarcoma is an extremely rare, highly malignant neoplasm, and only few cases had been reported in the literature worldwide. In the present study, we report an unusual case of a low-grade myofibroblastic sarcoma located in the posterior chest wall with intrathoracic propagation and discuss its clinical and pathological features.

          Related collections

          Most cited references6

          • Record: found
          • Abstract: found
          • Article: not found

          Low-grade myofibroblastic sarcoma: A population-based study.

          Low-grade myofibroblastic sarcoma (LGMS) is a rare entity that is described as having a predilection for occurring in the head and neck region. Here we analyze its demographics, clinic-pathologic, and survival characteristics.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Low-grade myofibroblastic sarcoma of the palate

            Low-grade myofibroblastic sarcoma (LGMS) is a rare, malignant tumor with myofibroblastic differentiation. Despite it being classified as a distinct entity by the World Health Organization, a few cases were reported in the oral and maxillofacial region. Here, a LGMS developed on the palate of a 73-year-old man who presented with a 1-cm tumor on the posterior border of the palate. Based on the histological and immunohistochemical features, a diagnosis of LGMS was established. The tumor was resected, and no recurrence was observed over 2 years. Although the tongue is the most preferred site for LGMS, it may occur in any region of the oral cavity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Low-grade myofibroblastic sarcoma arising in fibroadenoma of the breast-A case report–

              Background Myofibroblastic sarcoma or myofibrosarcoma is a malignant tumor of myofibroblasts and known to develop rarely in the breast, but its underlying lesion and tumor cell origin have never been reported yet. Case presentation A 61-year-old female presented with a gradually growing breast mass with well-demarcated ovoid nodular shape. The tumor was histologically characterized by fascicular-growing spindle cell proliferation with large areas of hyalinized fibrosis and focally ductal epithelial remnants embedded in myxoid stroma, mimicking a fibroadenomatous lesion. It had frequent mitoses of 5–16/10 high-power fields, hemorrhagic necrosis, and focally pericapsular invasion. The spindle cells were diffusely immunoreactive for fibronectin, smooth muscle actin, and calponin, which suggest a myofibroblastic origin. Multiple irregularly thickened vessels with medial or pericytic cell proliferation were found to be merged with the intrinsic tumor cells. The tumor could be diagnosed low-grade myofibroblastic sarcoma arising in an old fibroadenoma. Conclusion We report a case of a low-grade mammary myofibrosarcoma that showed a background lesion of fibroadenoma first in the worldwide literature and suggest the pericytes or medial muscle cells of the intratumoral vessels as the cell origin of the myofibroblastic sarcoma.
                Bookmark

                Author and article information

                Contributors
                +38531512800 , darkodominik@gmail.com
                ant2407@gmail.com
                Journal
                World J Surg Oncol
                World J Surg Oncol
                World Journal of Surgical Oncology
                BioMed Central (London )
                1477-7819
                3 May 2017
                3 May 2017
                2017
                : 15
                : 96
                Affiliations
                [1 ]ISNI 0000 0001 1015 399X, GRID grid.412680.9, Department of Internal Medicine, Faculty of Medicine, , J.J. Strossmayer University of Osijek, ; Cara Hadrijana 10/E, HR-31000 Osijek, Croatia
                [2 ]ISNI 0000 0004 0397 9648, GRID grid.412688.1, Department of Oncology, Faculty of Medicine, , University Hospital Centre Zagreb, ; Zagreb, Croatia
                Author information
                http://orcid.org/0000-0002-4433-338X
                Article
                1167
                10.1186/s12957-017-1167-7
                5415824
                28468630
                36be9873-a325-413d-9066-9f8bad42ddef
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 1 March 2017
                : 24 April 2017
                Categories
                Correspondence
                Custom metadata
                © The Author(s) 2017

                Surgery
                myofibroblastic sarcoma,chest wall,surgery,chemotherapy
                Surgery
                myofibroblastic sarcoma, chest wall, surgery, chemotherapy

                Comments

                Comment on this article